
Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - B
Batavia Biosciences B.V. Batavia Biosciences is a contract development and manufacturing organization, specialized in vaccines and gene therapies. |
|
Bavarian Nordic A/S Biopharmaceutical company developing and producing innovative vaccines by using vaccine (MVA) vectors for the development of vaccines against various infectious diseases such as smallpox, HIV/AIDS, as well as against breast and prostate cancer. |
|
BioCardia Inc BioCardia's Helix Biotherapeutic Delivery business remains committed to being the platform of choice for delivery of therapeutic agents to the myocardium. |
|
Bioheart, Inc. Biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Lead product candidate is MyoCell. |
|
Boster Bio Boster Bio specializes in the development and manufacturing of high-quality antibodies and ELISA kits, aiding scientific research in various fields such as cancer, neuroscience, and developmental biology. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy - Forbes
Sat, 15 Mar 2025 17:47:3 GMT - Regenxbio completes its BLA filing for first potential gene therapy for MPS II - The Pharma Letter
Sat, 15 Mar 2025 16:07:4 GMT - Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI to Pivotal Parkinson’s Trial - MedCity News
Fri, 14 Mar 2025 17:43:1 GMT - Cell and Gene Therapy Cold Chain Logistics Market Size By Dynamics Consumer Preferences Shaping Market Trends - openPR
Fri, 14 Mar 2025 16:17:0 GMT - Gene therapy efforts active, despite low Bluebird, 2seventy bids - BioWorld Online
Fri, 14 Mar 2025 16:00:0 GMT - US$200M Deal Accelerates Phase 3 Gene Therapy for Parkinsons - Streetwise Reports
Fri, 14 Mar 2025 15:22:0 GMT - Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free - Newsday
Fri, 14 Mar 2025 14:35:1 GMT - Coeptis licenses rights to gene therapy platform - Pennsylvania Business Report
Fri, 14 Mar 2025 13:11:0 GMT - MeiraGTx and Hologen launch AI-backed gene therapy venture - Pharmaceutical Technology
Fri, 14 Mar 2025 12:33:0 GMT - Trial launches of gene therapy vector for neurogenic bladder due to spinal cord injury - Urology Times
Fri, 14 Mar 2025 11:04:3 GMT - MeiraGTx Holdings Faces Financial Uncertainty Over Priority Review Vouchers for Gene Therapy - TipRanks
Fri, 14 Mar 2025 07:03:2 GMT - REGENXBIO Reports Progress in Gene Therapy Pipeline - TipRanks
Fri, 14 Mar 2025 05:55:1 GMT - ‘I’m Unstoppable’: New gene therapy cures first New Yorker of sickle cell anemia - PIX11 New York News
Thu, 13 Mar 2025 23:06:4 GMT - Gene therapy for Parkinson’s at heart of new AI collab - The Pharma Letter
Thu, 13 Mar 2025 20:14:1 GMT - Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025 - AJMC.com Managed Markets Network
Thu, 13 Mar 2025 19:00:0 GMT